The long-term effects of chemotherapy on normal blood cells
Emily Mitchell(Wellcome/MRC Cambridge Stem Cell Institute), Michael R. Stratton(Wellcome Sanger Institute), Michael Spencer Chapman(Wellcome Sanger Institute), Aditi Vedi(Wellcome/MRC Cambridge Stem Cell Institute), George Follows(Addenbrooke's Hospital), Laura Humphreys(University of Cambridge), Alex Cagan(University of Cambridge), Iñigo Martincorena(Wellcome Sanger Institute), Anna Santarsieri(Cambridge University Hospitals NHS Foundation Trust), Krishnaa T. Mahbubani(University of Cambridge), Raheleh Rahbari(Wellcome Sanger Institute), David G. Kent(University of York), Gary J. Doherty(Cambridge University Hospitals NHS Foundation Trust), Kourosh Saeb‐Parsy(University of Cambridge), E. Joanna Baxter(University of Cambridge), Daniel J. Hodson(Wellcome/MRC Cambridge Stem Cell Institute), Joanne I. Hsu(Brigham and Women's Hospital), Margaret A. Goodell(Baylor College of Medicine), Sandra Pietsch(Wellcome/MRC Cambridge Stem Cell Institute), Ultan McDermott(AstraZeneca (United Kingdom)), Rashesh Sanghvi(Wellcome Sanger Institute), Elisa Laurenti(Wellcome/MRC Cambridge Stem Cell Institute), Jyoti Nangalia(Wellcome Sanger Institute), Daniel Leonganmornlert(Wellcome Sanger Institute), Ellie Dunstone(Wellcome/MRC Cambridge Stem Cell Institute), Jingwei Wang(Wellcome Sanger Institute), Sarah Moody(Wellcome Sanger Institute), My H. Pham(Wellcome Sanger Institute), Koichi Takahashi(The University of Texas MD Anderson Cancer Center), Peter J. Campbell(Wellcome Sanger Institute), Hyunchul Jung(Wellcome Sanger Institute), Anna Clay(Babraham Institute), Heather E. Machado(University of Cambridge)
Cited by 4
Related Papers
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k
The cancer genome
|Nature|2009|3.5k
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
|The Lancet|2005|3.4k